Post-COVID-19 Cholangiopathy: Clinical and Radiologic Findings

Overview

Journal Korean J Radiol

Specialty Radiology

Date 2023 Oct 30

PMID 37899526

Authors

Hae Young Kim

Seung Soo Lee

Affiliations

Soon will be listed here.

Citing Articles

The Impact of Biliary Injury on the Recurrence of Biliary Cancer and Benign Disease after Liver Transplantation: Risk Factors and Mechanisms.

Wehrle C, Panconesi R, Satish S, Maspero M, Jiao C, Sun K Cancers (Basel). 2024; 16(16).

PMID: 39199562 PMC: 11352383. DOI: 10.3390/cancers16162789.

Incidence of Secondary Sclerosing Cholangitis in Hospitalized Long COVID-19 Patients: A Retrospective Single Center Study.

Werner C, Fusco S, Kienzle K, Dobele S, Artzner K, Malek N Diagnostics (Basel). 2024; 14(7).

PMID: 38611659 PMC: 11011916. DOI: 10.3390/diagnostics14070745.

Noteworthy Developments in the in 2023 and for 2024.

Park S Korean J Radiol. 2024; 25(1):1-5.

PMID: 38184762 PMC: 10788598. DOI: 10.3348/kjr.2023.1172.

References

Hunyady P, Streller L, Ruther D, Groba S, Bettinger D, Fitting D . Secondary Sclerosing Cholangitis Following Coronavirus Disease 2019 (COVID-19): A Multicenter Retrospective Study. Clin Infect Dis. 2022; 76(3):e179-e187. PMC: 9278244. DOI: 10.1093/cid/ciac565. View

Faruqui S, Okoli F, Olsen S, Feldman D, Kalia H, Park J . Cholangiopathy After Severe COVID-19: Clinical Features and Prognostic Implications. Am J Gastroenterol. 2021; 116(7):1414-1425. DOI: 10.14309/ajg.0000000000001264. View

Edwards K, Allison M, Ghuman S . Secondary sclerosing cholangitis in critically ill patients: a rare disease precipitated by severe SARS-CoV-2 infection. BMJ Case Rep. 2020; 13(11). PMC: 7654135. DOI: 10.1136/bcr-2020-237984. View

Roth N, Kim A, Vitkovski T, Xia J, Ramirez G, Bernstein D . Post-COVID-19 Cholangiopathy: A Novel Entity. Am J Gastroenterol. 2021; 116(5):1077-1082. DOI: 10.14309/ajg.0000000000001154. View

Hartl L, Haslinger K, Angerer M, Semmler G, Schneeweiss-Gleixner M, Jachs M . Progressive cholestasis and associated sclerosing cholangitis are frequent complications of COVID-19 in patients with chronic liver disease. Hepatology. 2022; 76(6):1563-1575. PMC: 9347407. DOI: 10.1002/hep.32582. View

Veerankutty F, Sengupta K, Vij M, Rammohan A, Jothimani D, Murali A . Post-COVID-19 cholangiopathy: Current understanding and management options. World J Gastrointest Surg. 2023; 15(5):788-798. PMC: 10277943. DOI: 10.4240/wjgs.v15.i5.788. View

Ghafoor S, Germann M, Jungst C, Mullhaupt B, Reiner C, Stocker D . Imaging features of COVID-19-associated secondary sclerosing cholangitis on magnetic resonance cholangiopancreatography: a retrospective analysis. Insights Imaging. 2022; 13(1):128. PMC: 9358102. DOI: 10.1186/s13244-022-01266-9. View

Faruqui S, Shanbhogue K, Jacobson I . Biliary Tract Injury in Patients With COVID-19: A Review of the Current Literature. Gastroenterol Hepatol (N Y). 2022; 18(7):380-387. PMC: 9666809. View

Yanny B, Alkhero M, Alani M, Stenberg D, Saharan A, Saab S . Post-COVID-19 Cholangiopathy: A Systematic Review. J Clin Exp Hepatol. 2022; 13(3):489-499. PMC: 9618303. DOI: 10.1016/j.jceh.2022.10.009. View

10.

Bernal-Monterde V, Casas-Deza D, Letona-Gimenez L, de la Llama-Celis N, Calmarza P, Sierra-Gabarda O . SARS-CoV-2 Infection Induces a Dual Response in Liver Function Tests: Association with Mortality during Hospitalization. Biomedicines. 2020; 8(9). PMC: 7555293. DOI: 10.3390/biomedicines8090328. View

11.

Kulkarni A, Khelgi A, Sekaran A, Reddy R, Sharma M, Tirumalle S . Post-COVID-19 Cholestasis: A Case Series and Review of Literature. J Clin Exp Hepatol. 2022; 12(6):1580-1590. PMC: 9187855. DOI: 10.1016/j.jceh.2022.06.004. View

12.

Seo N, Kim S, Lee S, Byun J, Kim J, Kim H . Sclerosing Cholangitis: Clinicopathologic Features, Imaging Spectrum, and Systemic Approach to Differential Diagnosis. Korean J Radiol. 2016; 17(1):25-38. PMC: 4720808. DOI: 10.3348/kjr.2016.17.1.25. View

13.

Heucke N, Keitel V . COVID-19-associated cholangiopathy: What is left after the virus has gone?. Hepatology. 2022; 76(6):1560-1562. PMC: 9350171. DOI: 10.1002/hep.32668. View

14.

. Intravenous ketamine and progressive cholangiopathy in COVID-19 patients. J Hepatol. 2021; 74(5):1243-1244. PMC: 7893247. DOI: 10.1016/j.jhep.2021.02.007. View